dc.contributor.author | Demirayak, Şeref | |
dc.contributor.author | Kayagil, İsmail | |
dc.date.accessioned | 2019-10-19T14:45:04Z | |
dc.date.available | 2019-10-19T14:45:04Z | |
dc.date.issued | 2007 | |
dc.identifier.issn | 0377-8282 | |
dc.identifier.uri | https://hdl.handle.net/11421/13679 | |
dc.description | WOS: 000248688400187 | en_US |
dc.description.abstract | … | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Prous Science, Sa | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | QSAR studies on anticancer activities of some 6,8-diarylimidazo[1,2-a]pyrazine derivatives | en_US |
dc.type | conferenceObject | en_US |
dc.relation.journal | Drugs of the Future | en_US |
dc.contributor.department | Anadolu Üniversitesi, Eczacılık Fakültesi, Farmasötik Kimya Anabilim Dalı | en_US |
dc.identifier.volume | 32 | en_US |
dc.identifier.startpage | 86 | en_US |
dc.identifier.endpage | 86 | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.contributor.institutionauthor | Demirayak, Şeref | |